11/5
08:00 am
ncna
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
Medium
Report
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
10/18
08:11 am
ncna
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025 [Yahoo! Finance]
Low
Report
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025 [Yahoo! Finance]
10/18
08:00 am
ncna
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
Low
Report
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
10/14
08:00 am
ncna
NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
Low
Report
NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
9/29
05:31 pm
ncna
DNA Synthesis Inhibitors Market Gains Momentum with Growing Adoption in Oncology and Virology | DelveInsight
High
Report
DNA Synthesis Inhibitors Market Gains Momentum with Growing Adoption in Oncology and Virology | DelveInsight
9/29
05:31 pm
ncna
DNA Synthesis Inhibitors Market Gains Momentum with Growing Adoption in Oncology and Virology | DelveInsight
High
Report
DNA Synthesis Inhibitors Market Gains Momentum with Growing Adoption in Oncology and Virology | DelveInsight